Andy Waldeck was named Global Managing Partner in 2022, and he is also a co-leader of Innosight’s healthcare practice. Over the past 15 years at Innosight, Andy has advised senior leaders at companies such as Aetna, Baxter, Covidien (now part of Medtronic), and Walgreens. He has extensive experience across the healthcare industry including, payers, providers, medical devices, pharmaceuticals, pharmacies, and health information technology.
At Innosight, Andy’s work focuses on helping clients to develop long-term growth strategies, manage enterprise transformation, build enduring growth and innovation capabilities and design new disruptive growth businesses. In addition to his work leading the healthcare practice, Andy also has worked with other Fortune 500 companies across the media, financial services and consumer industries.
Andy is a frequent speaker and author on topics of healthcare transformation, disruption and long-term growth. He is the co-author most recently of How Disruption can Finally Revolutionize Health Care, Knowing When to Reinvent and The New M&A Playbook.
Andy’s experience with growth and innovation stems from his past work with early-stage growth companies as both an investment banker and venture capitalist. Prior to joining Innosight, Andy was a Managing Director at the investment bank C.E. Unterberg, Towbin, where he completed 50 financial and strategic transactions totaling over $5B in transaction value. Most recently, Andy was a Vice President at GrandBanks Capital, an early stage IT-focused venture capital fund.
Andy received a B.A. in Business Economics from Brown University and an M.B.A with Distinction from the Tuck School of Business at Dartmouth, where he was a Tuck Scholar. He lives in Concord, MA with his wife and three children.
Harvard Business Review, 2015.
Harvard Business Review, 2011.